Cannabis Clinical Trials

Australia’s fledgling medicinal cannabis market continues to gain momentum, with MGC Pharmaceuticals planning an entry. MGC, which currently operates in Slovenia supplying non-psychoactive cannabidiol (CBD) resin extract to the growing European cosmetics and medical markets, has its sights set on becoming a leader in Australia’s medicinal cannabis market, worth $150 million a year. The company […]

A marijuana extract significantly reduced seizures in severely epileptic children, according to a landmark study conducted in part at Lurie Children’s Hospital of Chicago. Supporters said the results greatly improve the chances for the drug, called Epidiolex, to win eventual approval by federal regulators for prescription use to treat Dravet syndrome, a debilitating type of […]

Carrie Feibel | Houston Public MediaGloria and Ascencion Rodriguez, Jr., with Grace Scout, 3, who suffers severe epilepsy related to Dravet syndrome. The battle over medical marijuana, particularly when it involves children, has often been more about sentiment than science. But now researchers have results from the country’s first clinical trial using the drug for […]

A cannabis leaf. Photo: The United States Fish and Wildlife Service via Wikimedia Commons. JNS.org – American firms have invested about $50 million in licensing Israeli medical marijuana patents, cannabis agro-tech start-ups, and companies developing delivery devices such as inhalers, scientists say. “I expect it to grow to $100 million in the coming year,” Saul Kaye, […]

by

TEL AVIV Already a pioneer in high-tech and cutting-edge agriculture, Israel is starting to attract American companies looking to bring medical marijuana know-how to a booming market back home. Since 2014, U.S. firms have invested about $50 million in licensing Israeli medical marijuana patents, cannabis agro-tech startups and firms developing delivery devices such as inhalers, […]

by

When you think of cannabis and innovation, Israel likely doesn’t come to mind. But as we’ve recently highlighted here on MERRY JANE, Israel is advanced when it comes to cannabis-related exploration. Last week marked the second annual CannaTech conference, an international summit dedicated to accelerating cannabis innovation. The three-day event held in the capital city of Tel […]

by

With its moat, wall, barbed wire, armed guards and security cameras, the facility could be mistaken for a military base if it weren’t for the pungent odour of marijuana in the air.   Follow Ynetnews on Facebook and Twitter   Here, on the outskirts of a quiet village in northern Israel, 50,000 plants of 230 […]

by

by Paul Armentano, NORML Deputy Director March 22, 2016 Chronic pain patients with legal access to medicinal cannabis significantly decrease their use of opioids, according to data published online ahead of print in The Journal of Pain. Investigators at the University of Michigan, Ann Arbor conducted a retrospective survey of 244 chronic pain patients. All […]

by

Chronic pain patients with legal access to medicinal cannabis significantly decrease their use of opioids, according to data published online ahead of print in The Journal of Pain. Investigators at the University of Michigan, Ann Arbor conducted a retrospective survey of 244 chronic pain patients. All of the subjects in the survey were qualified under […]

by

A seemingly historic medical marijuana summit by several US government health agencies will largely exclude evidence coming from the states that have legalized medical cannabis — another example of entrenched Washington, DC bureaucrats placing politics over science in the marijuana debate. click to enlarge … read more at: http://www.eastbayexpress.com/LegalizationNation/archives/2016/03/22/historic-federal-summit-on-medicine-marijuana-is-slanted-by-drug-war-agenda

by

A marijuana-based drug has effectively treated children who suffer from a rare form of epilepsy known as Dravet syndrome in its first clinical trial, the drug’s manufacturer GW Pharmaceuticals announced on Monday. In a major victory for patients and legalization advocates, Epidiolex — a drug derived from a non-psychoactive component of marijuana known as cannabidiol […]

by